Biomarker-driven targeted therapy in patients with recurrent platinum-resistant epithelial ovarian cancer (BRIGHT): protocol for an open-label, multicenter, umbrella study.
Yu XuFan XiongHuayi LiHong ZhengJie JiangQingshui LiGuiling LiWeidong ZhaoRong LiJundong LiRong XieRuifang AnHuifeng ZhangQinglei GaoPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
ClinicalTrials.gov: NCT05044871.